Bioavailable Hormone Ratios represent the clinically relevant proportion of unbound, active hormones—such as free testosterone or free estradiol—relative to their total circulating levels, which are often bound to carrier proteins like SHBG or albumin. These ratios dictate the actual hormonal signal delivered to target tissues, providing a superior metric for assessing endocrine function compared to total hormone measurements alone. Proper ratio assessment is paramount for interpreting endocrine status accurately.
Origin
The term evolved from recognizing the limitations of measuring only total hormone concentrations, which can be misleading if carrier protein saturation varies widely among individuals. It stems from the biophysics of protein binding dynamics and the necessity of determining the fraction capable of diffusing into cells to interact with intracellular receptors. This refinement anchors hormone assessment in physiological effect rather than mere mass concentration.
Mechanism
The ratio functions as a dynamic indicator of receptor accessibility, determined by the equilibrium between free hormone, bound hormone, and receptor occupancy. Factors influencing this mechanism include the concentration and binding affinity of Sex Hormone Binding Globulin (SHBG) and albumin, which act as circulating reservoirs. Optimizing these ratios ensures that target tissues receive the necessary hormonal signal strength for appropriate cellular response.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.